Hospital
Clhg-Winn, LLC
Clhg-Winn, LLC was paid $3.06M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99284, emergency room visit (serious) — 37% of everything it billed.
33Billing provider infoCLHG-WINN, LLC
WINNFIELD, LA 71483
WINNFIELD, LA 71483
33aNPI1205833241assigned 07/06/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.06M
24GClaims66,460
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#58 of 96
Median peer was paid$5.17M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,610 | $304K | |
| 2019 | 7,466 | $211K | |
| 2020 | 5,091 | $135K | |
| 2021 | 10,757 | $370K | |
| 2022 | 13,518 | $523K | |
| 2023 | 12,296 | $766K | |
| 2024incomplete | 8,722 | $749K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 6,292 | 5,504 | $1.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 10,064 | 9,047 | $1.03M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,524 | 1,313 | $335K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.3% | 3,637 | 3,216 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 9,521 | 7,791 | $51K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 1,099 | 938 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 2,428 | 1,928 | $39K |
| 80053 | Comprehensive metabolic panel | 1.0% | 4,942 | 4,214 | $32K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 388 | 347 | $28K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 73 | 63 | $19K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 978 | 209 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 323 | 251 | $16K |
52 more codes
| 87276 | <1% | 1,318 | $16K | |
| 83735 | <1% | 3,679 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,159 | $14K |
| 87275 | <1% | 1,317 | $12K | |
| 87400 | <1% | 1,102 | $12K | |
| 86710 | <1% | 1,149 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 217 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 803 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,550 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,738 | $7K |
| G0378 | Hospital observation service, per hour | <1% | 60 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 169 | $7K |
| 94761 | <1% | 478 | $7K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 68 | $7K |
| 87070 | <1% | 789 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 94 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 971 | $5K |
| 93041 | <1% | 299 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $4K |
| 80061 | Lipid panel | <1% | 364 | $4K |
| 80050 | General health panel | <1% | 80 | $3K |
| 97161 | <1% | 92 | $3K | |
| 81003 | <1% | 2,061 | $3K | |
| 81025 | <1% | 386 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 52 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 165 | $2K |
| 84481 | <1% | 120 | $1K | |
| 83880 | <1% | 94 | $1K | |
| 84439 | <1% | 169 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 58 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 17 | $774.04 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $740.66 |
| 81001 | <1% | 319 | $692.05 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 68 | $361.35 |
| 82607 | <1% | 13 | $196.04 | |
| 82746 | <1% | 13 | $191.10 | |
| 82553 | <1% | 35 | $166.41 | |
| 84484 | <1% | 33 | $162.11 | |
| 80069 | <1% | 30 | $156.24 | |
| 83540 | <1% | 32 | $155.28 | |
| 82728 | <1% | 14 | $149.93 | |
| 83525 | <1% | 16 | $138.12 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 20 | $114.56 |
| 82550 | <1% | 36 | $113.34 | |
| 86140 | <1% | 13 | $67.34 | |
| 85651 | <1% | 19 | $38.43 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 29 | $32.64 |
| J2704 | Injection, propofol, 10 mg | <1% | 442 | $30.14 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 114 | $24.50 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 240 | $0.00 |
| 00000 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEWIS, MONICA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Clhg-Winn, LLC | Winnfield, LA | $3.30M |
| Clhg-Winn, LLC | Winnfield, LA | $177K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.